Is Extracorporeal CO2 Removal Really "safe" and "less" Invasive? Observation of Blood Injury and Coagulation Impairment during ECCO2R

ASAIO Journal

Volumn 63, Issue 5, 2017, Pages 666-671

  Kalbhenn, Johannes ^a   Neuffer, Nadine ^a   Zieger, Barbara ^b   Schmutz, Axel ^a  

^a Department of Anesthesiology and Critical Care ^*  (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

acquired von Willebrand syndrome; ARDS; bleeding; CO2 dialysis; ECCO2R

Indexed keywords

BLOOD; CARBON DIOXIDE; CELLS; COAGULATION;

CO2 REMOVAL; EXTRACORPOREAL SYSTEMS; HIGH MOLECULAR WEIGHT; OBSERVATIONAL STUDY; RED BLOOD CELL; RESPIRATORY FAILURE; THROMBOCYTOPENIA; VON WILLEBRAND FACTOR;

PATIENT TREATMENT;

CARBON DIOXIDE; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 13 DEFICIENCY; CLINICAL ARTICLE; ERYTHROCYTE TRANSFUSION; EXTRACORPOREAL CIRCULATION; FEMALE; HEMOLYSIS; HUMAN; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RESPIRATORY FAILURE; THORAX SURGERY; THROMBOCYTOPENIA; THROMBOSIS; VON WILLEBRAND DISEASE; AGED; BLEEDING; BLOOD; EXTRACORPOREAL OXYGENATION; PROSPECTIVE STUDY;

ADULT; AGED; CARBON DIOXIDE; EXTRACORPOREAL CIRCULATION; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RESPIRATORY INSUFFICIENCY;

EID: 85012181050     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0000000000000544     Document Type: Article

References (34)

1. Terragni P, Maiolo G, Ranieri VM: Role and potentials of low-flow CO(2) removal system in mechanical ventilation. Curr Opin Crit Care 18: 93-98, 2012.
2. Fanelli V, Ranieri MV, Mancebo J, et al: Feasibility and safety of low-flow extracorporeal carbon dioxide removal to facilitate ultra-protective ventilation in patients with moderate acute respiratory distress syndrome. Crit Care 20: 36, 2016.
3. Braune S, Sieweke A, Brettner F, et al: The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR study): multicentre case-control study. Intensive Care Med 42: 1437-1444, 2016.
4. Abrams DC, Brenner K, Burkart KM, et al: Pilot study of extracorporeal carbon dioxide removal to facilitate extubation and ambulation in exacerbations of chronic obstructive pulmonary disease. Ann Am Thorac Soc 10: 307-314, 2013.
5. Bonin F, Sommerwerck U, Lund LW, Teschler H: Avoidance of intubation during acute exacerbation of chronic obstructive pulmonary disease for a lung transplant candidate using extracorporeal carbon dioxide removal with the Hemolung. J Thorac Cardiovasc Surg 145: e43-e44, 2013.
6. Deniau B, Ricard JD, Messika J, Dreyfuss D, Gaudry S: Use of extracorporeal carbon dioxide removal (ECCO2R) in 239 intensive care units: results from a French national survey. Intensive Care Med 42: 624-625, 2016.
7. Gattinoni L, Kolobow T, Tomlinson T, et al: Low-frequency positive pressure ventilation with extracorporeal carbon dioxide removal (LFPPV-ECCO2R): an experimental study. Anesth Analg 57: 470-477, 1978.
8. Müller T, Lubnow M, Philipp A, et al: Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy. Eur Respir J 33: 551-558, 2009.
9. Bein T, Weber-Carstens S, Goldmann A, et al: Lower tidal volume strategy (approximately 3 ml/kg) combined with extracorporeal CO2 removal versus 'conventional' protective ventilation (6 ml/ kg) in severe ARDS: the prospective randomized Xtravent-study. Intensive Care Med 39: 847-856, 2013.
10. Gattinoni L, Pesenti A, Mascheroni D, et al: Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. JAMA 256: 881-886, 1986.
11. Braune S, Sieweke A, Brettner F, et al: The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR study): multicentre case-control study. Intensive Care Med 42: 1437-1444, 2016.
12. da Rocha AC, da Silva AB, de Brito AB, et al: Virulence factors of avian pathogenic Escherichia coli isolated from broilers from the south of Brazil. Avian Dis 46: 749-753, 2002.
13. Amilien V, Ponthus JP, Ngasseu P, et al: Feasibility of the implementation of a technic of extra-corporeal Co2 removal (ECCO2R) in an intensive care unit which doesn't use ECMO and its real utilization. Intensive Care Med Exp 3 (suppl 1): A505, 2015.
14. Zangrillo A, Landoni G, Biondi-Zoccai G, et al: A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Crit Care Resusc 15: 172-178, 2013.
15. Kalbhenn J, Wittau N, Schmutz A, Zieger B, Schmidt R: Identification of acquired coagulation disorders and effects of target-controlled coagulation factor substitution on the incidence and severity of spontaneous intracranial bleeding during veno-venous ECMO therapy. Perfusion 30: 675-682, 2015.
16. Kalbhenn J, Schmidt R, Nakamura L, Schelling J, Rosenfelder S, Zieger B: Early diagnosis of acquired von Willebrand Syndrome (AVWS) is elementary for clinical practice in patients treated with ECMO therapy. J Atheroscler Thromb 22: 265-271, 2015.
17. Panigada M, Artoni A, Passamonti SM, et al: Hemostasis changes during veno-venous extracorporeal membrane oxygenation for respiratory support in adults. Minerva Anestesiol 82: 170-179, 2016.
18. Batchinsky AI, Jordan BS, Regn D, et al: Respiratory dialysis: reduction in dependence on mechanical ventilation by venovenous extracorporeal CO2 removal. Critical Care Med 39: 1382-1387, 2011.
19. Burki NK, Mani RK, Herth FJ, et al: A novel extracorporeal CO(2) removal system: results of a pilot study of hypercapnic respiratory failure in patients with COPD. Chest 143: 678-686, 2013.
20. Konkle BA: Acquired disorders of platelet function. Hematology Am Soc Hematol Educ Program 2011: 391-396, 2011.
21. Görlinger K, Bergmann L, Dirkmann D: Coagulation management in patients undergoing mechanical circulatory support. Best Pract Res Clin Anaesthesiol 26: 179-198, 2012.
22. Plötz FB, van Oeveren W, Bartlett RH, Wildevuur CR: Blood activation during neonatal extracorporeal life support. J Thorac Cardiovasc Surg 105: 823-832, 1993.
23. Kalbhenn J, Wittau N, Schmutz A, Zieger B, Schmidt R: Identification of acquired coagulation disorders and effects of target-controlled coagulation factor substitution on the incidence and severity of spontaneous intracranial bleeding during veno-venous ECMO therapy. Perfusion 30: 675-682, 2015.
24. Kalbhenn J: Hemostasis and extracorporeal membrane oxygenation: bleeding cannot be seen in aliquots. Crit Care Med 44: e591-e592, 2016.
25. Nascimbene A, Neelamegham S, Frazier OH, Moake JL, Dong JF: Acquired von Willebrand syndrome associated with left ventricular assist device. Blood 127: 3133-3141, 2016.
26. Heilmann C, Geisen U, Beyersdorf F, et al: Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS). Intensive Care Med 38: 62-68, 2012.
27. Heilmann C, Geisen U, Beyersdorf F, et al: Acquired Von Willebrand syndrome is an early-onset problem in ventricular assist device patients. Eur J Cardiothorac Surg 40: 1328-1333, 2011; discussion 1233.
28. Baldauf C, Schneppenheim R, Stacklies W, et al: Shear-induced unfolding activates von Willebrand factor A2 domain for proteolysis. J Thromb Haemost 7: 2096-2105, 2009.
29. Federici AB, Rand JH, Bucciarelli P, et al: Acquired von Willebrand syndrome: data from an international registry. Thromb Haemost 84: 345-349, 2000.
30. Mohri H: Acquired von Willebrand syndrome: features and management. Am J Hematol 81: 616-623, 2006.
31. Tauber H, Ott H, Streif W, et al: Extracorporeal membrane oxygenation induces short-term loss of high-molecular-weight von Willebrand factor multimers. Anesth Analg 120: 730-736, 2015.
32. Korte W: F. XIII in perioperative coagulation management. Best Pract Res Clin Anaesthesiol 24: 85-93, 2010.
33. Gödje O, Gallmeier U, Schelian M, Grünewald M, Mair H: Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation. Thorac Cardiovasc Surg 54: 26-33, 2006.
34. Vandiver JW, Vondracek TG: Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparin. Pharmacotherapy 32: 546-558, 2012.